Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01782976
Brief Title: Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

First Submitted : January 31, 2013
First Submitted that Met QC Criteria : January 31, 2013
First Posted : February 4, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : January 17, 2018
Last Update Posted : January 19, 2018